agilon health(US:AGL) Globenewswire·2026-01-27 18:17Core Viewpoint - Agilon Health, Inc. is facing a securities fraud class action lawsuit, with a deadline for investors to act by March 2, 2026 [1][3][4]. Group 1: Lawsuit Details - The lawsuit was filed in the United States District Court for the Eastern District of New York on behalf of investors who purchased or acquired Agilon securities between February 26, 2025, and August 4, 2025 [4]. - The allegations include violations of the Securities Exchange Act of 1934, with claims that the Company and certain senior officers made misrepresentations regarding the Company's issued guidance for 2025 [4]. Group 2: Investor Actions - Investors who wish to serve as lead plaintiffs must file necessary papers by March 2, 2026, although participation in any recovery does not require serving as a lead plaintiff [3]. - Shareholders are informed that all representation is on a contingency fee basis, meaning they pay no fees or expenses [3]. Group 3: Legal Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for clients since its inception in 1993 and has represented both individual investors and large pension funds [5]. - The firm has been recognized for its success in litigating class actions, being named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for sixteen consecutive years [5].